The QT interval (QT) reflects cardiac ventricular repolarization and varies according to various known factors such as heart rate, gender and age. Nevertheless, a high intrasubject stability of the QT-RR pattern also suggests that a genetic component contributes to individual QT length. To determine whether single nucleotide polymorphisms (SNPs) in genes encoding cardiac ion channels were associated with the heartrate corrected QT (QTc) length, we analyzed two groups of 200 subjects presenting the shortest and the longest QTc from a cohort of 2008 healthy subjects. A total of 17 polymorphisms were genotyped; they were all in the Hardy -Weinberg equilibrium in both groups. Neither allele nor haplotype frequencies of the 10 KCNQ1 SNPs showed a significant difference between the two groups. In contrast, KCNH2 2690 C (K897T) and SCN5A 5457 T (D1819D) minor alleles were significantly more frequent in the group with the shortest QTc interval, whereas KCNE1 253 A (D85N), SCN5A 1673 G (H558R) and 1141-3 A minor alleles were significantly more frequent in the group with the longest QTc interval. Interestingly, an interaction was also found between the KCNH2 2690 A4C SNP and the KCNQ1 2031 þ 932 A4G SNP suggesting that the effect of the KCNH2 2690 C allele on QTc length may occur within a particular genetic background. This suggests that genetic determinants located in KCNQ1, KCNE1, KCNH2 and SCN5A influence QTc length in healthy individuals and may represent risk factors for arrhythmias or cardiac sudden death in patients with cardiovascular diseases.
Introduction
The QT interval (QT), measured on the electrocardiogram (ECG), reflects cardiac ventricular repolarization. In healthy populations, its length varies widely and several factors such as heart rate, gender and age exert an influence on the QT length. 1, 2 Indeed, women present relative QT prolongation compared with men 3, 4 and QT shortens in men after puberty. 2 Whereas there exists a substantial interindividual variability of the QT-RR relationship, which represents the relationship between QT duration and heart rate, a high intraindividual stability of the QT-RR pattern has been shown, suggesting that a genetic component might partly determine individual QT length. 5, 6 Indeed, Busjahn et al 7 have shown a significant linkage in dizygotic twins between heart rate-corrected QT interval (QTc) and two loci harboring genes known to cause the long QT syndrome (LQTS). Ventricular action potential (AP) is under the joint control of the depolarizing Na þ (I Na ) and the repolarizing slow (I Ks ) and rapid (I Kr ) K þ -delayed rectifier currents. The activity and expression levels of each of these current-underlying channels establish a subtle equilibrium between depolarizing and repolarizing currents determining the AP duration in each individual. Thus, it would not be surprising that polymorphisms in the genes coding for these channels may influence this equilibrium even by weak effects on activity and/or expression level of channels subunits.
The cardiac I Na current is underlined by the a Na v 1.5 subunit channel encoded by the SCN5A gene. As for the K þ -delayed rectifier current, the I Ks current is elicited by the a KvLQT1 and b minK subunits encoded by the KCNQ1 and KCNE1 genes, respectively, and the I Kr current by the a HERG and b Mirp1 subunits encoded, respectively, by the KCNH2 and KCNE2 genes. 8 -11 Mutations in these ion channel subunits are responsible for the LQTS, where a decrease in outward K þ current or an increase in inward Na þ current results in a prolongation of the AP. This prolongation, leading to a prolonged QT interval on baseline ECG, renders patients at high risk of developing torsades de pointes or ventricular fibrillation leading to syncope or sudden death. However, more recently, mutations in KCNH2 and KCNQ1, leading to an increase in outward K þ current, have also been linked to the short QT syndrome (SQTS). In SQTS, a drastic decrease of the QTc interval is also linked to life-threatening arrhythmias and sudden death. 12, 13 It is now widely recognized that penetrance of these monogenic arrhythmias is highly variable. In other words, among individuals carrying the same causative mutation within a specific affected kindred, some express a clinical phenotype whereas others do not manifest a phenotype. 14 Variability elsewhere in the genome, such as polymorphisms in the same disease-causing gene or in other genes, might contribute to this variable penetrance as well as to the appearance of a clinical phenotype. For example, the SCN5A H558R variant which is a common polymorphism in the American population, 15 was shown to mitigate the in vitro effects of a nearby mutation on the Na þ channel function 16 whereas coinheritance of the SCN5A D1275N variant with a rare haplotype in the Cx40 gene was associated with an atrial standstill phenotype in a kindred. 17 It has also been shown that not only rare mutations 11, 15, 18 but also polymorphisms in KCNE1, KCNE2
and SCN5A could represent risk factors for drug-induced arrhythmias. 18 -20 Some polymorphisms have already been reported to be associated with the QTc length. The K897T amino-acid variant of KCNH2 was associated with the length of QT interval in Finnish LQT1 patients. 21 Bezzina et al 22 reported
in healthy women, that homozygote carriers for the T897 allele had shorter QTc than homozygote for the K897 allele. Very recently, single nucleotide polymorphisms (SNPs) in other ion channel subunits were also associated with the QTc length in healthy individuals. 23 Given the major role of cardiac sodium and potassium channels in ventricular repolarization, we investigated the potential association of 10 KCNQ1, two KCNE1, four SCN5A polymorphisms and the KCNH2 K897T variant with the QTc length in a healthy French population. We also tested whether these SNPs might interact to influence on the QTc duration.
Material and methods

Study population
Participants of the Data from an Epidemiological Study on the Insulin Resistance syndrome (D.E.S.I.R.) cohort gave informed consent to the clinical and genetic study, which was approved by an ethics committee. The investigations conform to the principles outlined in the Declaration of Helsinki.
The D.E.S.I.R. study The study subjects were selected from the D.E.S.I.R. cohort, which included French men and women aged 30 -64 years. Participants were volunteers who agreed to be followed for 9 years and to have a clinical examination every 3 years. This study involved 10 health examination centers in France. 24, 25 The first examination took place in 1994 (D0) and the second in 1997 (D3). Blood pressure was measured after at least 5 min rest and venous blood samples were collected to determine glucose, triglyceride and HDL-cholesterol concentrations. Disease history (diabetes, hypertension, cardiovascular disease, etc), medical treatment, physical activity, alcohol and tobacco consumption were collected for each subject.
Subjects underwent a 12-lead resting ECG. QT intervals were measured in lead II (ms) by Cardionics s software and corrected for heart rate by use of the Fridericia formula (QTc). 26 Subjects with an ECG recording at D0 and D3
(n ¼ 3478) form the basis of the study. We excluded the subjects (n ¼ 1399) with known or detected cardiac pathology, diabetes (defined by use of treatment or a fasting plasma glucose level (Z7.0 mmol/l)), treated or untreated high blood pressure as well as the subjects taking medication known to prolong the QT interval such as neuroleptics, antiarrhythmics or antihistaminics, at D0 and D3. Subjects with a difference Z30 ms in QTc between the two examinations were also excluded (n ¼ 71). The distribution of the mean QTc values (averaged on measures at D0 and D3) of the remaining healthy subjects (n ¼ 2008) is shown in the Supplementary Figure 1 . Mean QTc values were adjusted for age, separately in men and women, and the residuals were used to select the 100 men Ion channel gene polymorphisms and QTc length L Gouas et al and 100 women with the shortest QTc, and 100 men and 100 women with the longest QTc. In a preliminary study, the KCNQ1 exons had been sequenced in the 50 men and 50 women with the longest QTc, and two new KCNQ1 mutations had been identified (Y148X, DS276). 27 The two carriers of these mutations whose QTc interval prolongation was assumed to be due to these mutations were excluded from the study.
Genetic analysis
Genomic DNA amplification Genomic DNA was prepared from peripheral blood lymphocytes by standard procedures. Previously designed primers were used to amplify the KCNQ1 exons by PCR. 28 Primers used to amplify KCNQ1 3 0 UTR region, KCNE1, SCN5A and KCNH2 DNA sequences are given on the European Journal of Human Genetics website.
Sequence analysis DNA sequences containing the KCNQ1 2031 þ 479 G4A, 2031 þ 875 A4G and 2031 þ 932 A4G, the KCNE1 112 G4A and 253 G4A, and the SCN5A -92 C4A polymorphisms were amplified by PCR using a GeneAmp ThermoCycler 9700 (Applied Biosystems). The PCR products were cleaned up using BioGel s P-100 Gel (Bio-Rad) spin columns in a MultiScreent 96-well filter plate (Milipore). The sequencing reactions were performed by the dideoxynucleotide chain termination method with fluorescent dideoxynucleotides according to the dGTP Big Dye s Terminator v3.0 protocol, then cleaned up using Sephadext G50 Superfine (Amersham Biosciences) spin columns in a MultiScreent 96-well filter plate. The reactions were run on an ABI 377 (Applied Biosystems).
Fluorescent-SSCP (F-SSCP) DNA sequences containing the KCNQ1 477 þ 80 insGG, 1514 þ 46 A4G, 1590 þ 14 T4C, 1638 G4A, 1732 þ 43 T4C and 1794 þ 32 G4T were amplified by PCR using ThermoCyclert 9700 (Applied Biosystem). PCR was carried out using fluorescent-dyelabeled sense and antisense primers specific for the DNA region of interest (6FAMt, HEXt). In all, 0.5 -2 ml of PCR amplicons were mixed to a denaturing buffer (50% formamide, 25 mg dextran blue (50 mg/ml), 2.5 mM EDTA (25 mM)) and to a DNA molecular weight standard (GENESCAN-500 Rox, Applied Biosystem). Samples were then denatured 5 min at 941C and quenched on ice. In all, 1 ml of samples was applied to a nondenaturing gel (MDE 0.5X, MGDA) and electrophoresed on the ABI 377 system. The mobility of F-SSCP fragments was measured relative to ROX size standard by use of Genescan 3.1.2 software (Applied Biosystems).
Fluorescence resonance energy transfer and probe melting curves The KCNQ1 1986 C4T and 2031 þ 875 A4G (n ¼ 400 and 200, respectively), the KCNH2 2690 A4C and the SCN5A 1673 A4G, 5457 C4T and 1141 -3 C4A polymorphisms were analyzed by Fluorescence Resonance Energy Transfer within a LightCycler (Roche Diagnostics). In all, 40 ng of sample DNA was used to perform a 25 ml PCR reaction containing the detection probe and the anchor probe for the KCNQ1 1986 C4T, KCNH2 2690 C4A, SCN5A 1673 A4G, 5457 C4T and 1141-3 C4A polymorphisms in a GeneAmp ThermoCycler 9700 system (Perkin Elmer). PCR amplicons were then loaded into glass capillary cuvettes (Roche Diagnostics). After an initial denaturation step at 951C for 30 s, a melting curve was recorded by cooling the reaction mixture to 401C at 201C/s, holding it at 401C for 120 s, and then slowly heating it to 851C at 0.11C/s. Fluorescence was measured continuously during the slow temperature ramp to monitor the dissociation of the fluorescein-labeled detection probe. For the KCNQ1 2031 þ 875 A4G, 40 ng of sample DNA was used to do PCR reactions in the LightCycler in a reaction volume of 20 ml with 0.4 mmol/l of each primer, 0.06 mmol/l anchor and detection probes, 3 mmol/l MgCl 2 and 2 ml of the Master Mix Hybridyzation Probes (Roche Diagnostics). After an initial denaturation step at 951C for 30 s, amplification was performed using 40 cycles of denaturation (951C for 3 s), annealing (551C for 10 s) and extension (721C for 15 s). The temperature transition rates were programmed at 201C/s from denaturation to annealing, 51C/s from annealing to extension, and 201C/s from extension to denaturation. After amplification was complete, a final melting curve was recorded as described above.
Statistical analysis
The difference between the mean QTc value between the two groups for men and women was assessed by a MannWhitney Rank Sum test (SygmaStat). Deviation from the Hardy -Weinberg equilibrium was tested by w 2 analysis with 1 degree of freedom in the shortest and longest QTc groups separately. Pairwise linkage disequilibrium (LD) coefficients between polymorphisms were estimated by log-linear model analysis 29 and the extent of disequilibrium was expressed in terms of
Allele frequencies were estimated from genotype frequencies by gene counting. The study was analyzed as a case/ control study comparing the longest and the shortest QTc groups. Genotype and allele frequencies were compared between the two groups by w 2 test. Homogeneity of the association according to gender was systematically tested and since there was no heterogeneity for any of the polymorphisms, men and women were pooled for analysis. The odds ratio (OR) [95% CI] for longest QTc associated with genotype was estimated from logistic regression analysis adjusted for age and sex. A P-value o0.05 was considered statistically significant. All computations were carried out with the SAS software (SAS Institute, Cary, NC, USA).
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To analyze simultaneously all polymorphisms of a gene, haplotype analyses were performed by use of a maximum likelihood model 30 implemented in the THESIAS program (http://www.genecanvas.org). In these analyses, the haplotype combining the most frequent alleles at each locus was used as the reference. We applied the detection of informative combined effect (DICE) method 31 to investigate high-order interactions between polymorphisms of the different genes on the phenotype. Briefly, the DICE algorithm explores in an automated way all combinations of polymorphisms acting either in an additive or in an interactive way (three-order interaction at maximum). Models of increasing complexity are successively fitted to data and the difference D s of the Akaike's information criterion between models indicates whether the fit is substantially improved, that is, when D s exceeds a predetermined threshold. The algorithm stops when no model leads to a D s higher than the fixed threshold. Given the large number of polymorphisms investigated, a rather stringent threshold was chosen (D s 46). In this analysis, a dominant coding scheme for polymorphisms was adopted (frequent homozygotes opposed to carriers of the minor allele).
Results
Baseline characteristics of the two groups are presented in Table 1 .
KCNQ1 polymorphisms
In a preliminary study, the KCNQ1 exons had been sequenced in the 100 subjects with the longest QTc intervals and 18 SNPs were found. In Table 2 we report the SNP position, the SNP Identity (ID) from public databases, when available, and their allele frequencies. According to arrhythmia literature, the National Center for 
There was no deviation from the Hardy -Weinberg equilibrium for any of the polymorphisms considered. The frequency of the minor allele ranged from 0.05 to 0.42 ( Table 2 ). The three polymorphisms in the 3 0 end of the gene and the polymorphism 1986 C4T in exon 15 were in strong LD with each other (absolute pairwise LD coefficients ranging from 0.68 to 0.90). Moreover, the 2031 þ 875 A4G and 2031 þ 932 A4G SNPs were in nearly complete association (only 9.8% of the subjects were recombinants). Conversely, the polymorphisms located upstream from exon 15 exhibited very weak LD. The detailed LD coefficients can be found in the web supplement (Table A, web supplement).
None of the KCNQ1 polymorphisms exhibited significant difference of genotype or allele frequencies between the groups with the shortest and the longest QTc intervals (data not shown). Given the strong LD between polymorphisms located in exon 15 and 3 0 UTR, a haplotype analysis of these four polymorphisms was performed. They generated six common haplotypes, which were similarly distributed between the two groups.
KCNE1 polymorphisms
The known SNPs, 112 G4A and 253 G4A, leading to the amino-acid changes G38S and D85N, respectively, were analyzed. Genotype frequencies did not deviate from the Hardy -Weinberg equilibrium in either group. The two polymorphisms were in weak LD (D 0 ¼ À0.46) ( Table B , web supplement).
Allele and genotype frequencies of the 112 G4A SNP (G38S) did not differ significantly between the two groups ( 
SCN5A polymorphisms
In this study, four SCN5A SNPs were analyzed: 1141-3 C4A in intron 9, 1673 A4G in exon 12, leading to the aminoacid change H558R, 5457 C4T in exon 28 leading to the Carriers of the minor allele opposed to homozygotes for the frequent allele; ***P ¼ 0.016.
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synonymous polymorphism D1819D, and À92 C4A in the core promoter of the gene.
The minor allele frequencies were 0.20 for 1141-3 A, 0.24 for 1673 G, 0.31 for 5457 T, and 0.003 (two out of 780 alleles) for À92 A. This latest SNP was less represented in our population than in the previous sample of 71 subjects of mixed ethnicity (N ¼ 71, 4.2%). 34 Owing to its low frequency, it was not studied further. The three frequent SNPs were in the Hardy -Weinberg equilibrium in the two groups.
The 1141-3 C4A and 1673 A4G SNPs were in strong association, with only 8.3% of recombinant subjects. These two polymorphisms were in weak LD with the 5457 C4T polymorphism (Table C, (Table 5) . Conversely, the minor allele 5457 T was more frequent in the group with the shortest QTc interval and associated with a lower risk of QTc interval prolongation (OR ¼ 0.65 [0.48 -0.89], P ¼ 0.0063) ( Table 5) .
A haplotype analysis combining the 1141-3 C4A SNP and the 5457 C4T polymorphisms was performed. The 1673 A4G polymorphism was not included in the haplotype analysis because of its high concordance with the 1141-3 C4A. There was a globally significant difference in haplotype distribution between the two groups (P ¼ 0.002) ( Table 6 ). We examined whether the effect of each polymorphism had an independent effect on risk by testing the interaction between the two alleles, but this did not reach significance (P ¼ 0.65), indicating that the two polymorphisms acted independently from each other.
Interaction between polymorphisms among the four genes Potential interactions between polymorphisms of the different genes were explored in a systematic way. An interaction was detected between the KCNH2 2690 A4C SNP and the KCNQ1 2031 þ 932 A4G polymorphism. Actually, the effect of the KCNH2 2690 C allele previously observed appeared to be confined to homozygotes for the major Carriers of the minor allele opposed to homozygotes for the frequent allele; *P ¼ 0.0057, **P ¼ 0.0210, ***P ¼ 0.0032. Global difference in haplotype frequencies between the shortest and longest QTc groups: P ¼ 0.002.
Discussion
While gender and age influence QT duration, a genetic determination of the QT length has been suggested. 7 Several studies have focused on SNPs located in genes responsible for the LQTS as potential determinants of cardiac repolarization duration. Indeed, the cardiac AP is orchestrated by potassium and sodium ion channel subunits encoded by the KCNQ1 (LQT1), KCNE1 (LQT5), KCNH2 (LQT2), KCNE2 (LQT6) and SCN5A (LQT3) genes, in which rare mutations lead to QTc prolongation associated with ventricular arrhythmias. The first SNPs found associated with the QTc length in healthy subjects were 2690 A4C (K897T) of KCNH2 21, 22, 32 and, more recently, SNPs in KCNQ1, KCNE1, KCNE2 and SCN5A.
23,35
While these studies determined the impact of SNPs on QT length as a quantitative trait, we adopted an original approach by opposing two contrasted groups of healthy untreated subjects: 200 subjects presenting the shortest and 198 subjects presenting the longest QTc interval length, selected from a cohort of 2008 healthy subjects. We then compared the allele, genotype and haplotype frequencies of 10 KCNQ1, two KCNE1, four SCN5A and one KCNH2 SNPs between the two groups and searched for potential interactions between them.
KCNQ1 and KCNE1 polymorphisms
We screened the entire coding sequence, exon/intron boundaries and the 3 0 UTR region of the KCNQ1 gene and identified six new rare SNPs (o0.10) (459 G4T (T153 T), 477 þ 20 A4G, 918 þ 13 C4T, 984 C4T (I328I), 1514 þ 7 G4T and 1514 þ 14 G4T), and two more frequent ones (40.10) (477 þ 80 insGG, 2031 þ 479 G4A).
Busjahn et al 7 initially suggested that the LQT1 locus, containing KCNQ1, may represent a quantitative trait locus (QTL) for the QTc phenotype in the normal population. However, in our study, no KCNQ1 SNPs, alone or in combination, demonstrated an association with the QTc length. In a recent study, Aydin and al 23 also failed to identify KCNQ1 SNPs associated with QTc length in the normal monozygotic and dizygotic twins previously studied by Busjahn. The discrepancy between results from linkage and association studies suggests that a different gene in the vicinity of KCNQ1 might be at the origin of the linkage previously detected in the region. Another explanation might be that there exists in KCNQ1 an undetected functional SNP not in complete LD with the SNPs genotyped in the present study as well as in Aydin's report. 23 Besides, in a recent report analyzing 81 SNPs spreading over the entire KCNQ1 gene, several haplotype blocks were identified in weak LD one with each other, and a rare G allele (rs757092 A4G) in a high LD haplotype block in intron 1 was associated with a QTc prolongation in the study population. 35 The 477 þ 80 insGG polymorphism is located 50 kb downstream from the rs757092 A4G SNP in the genomic sequence of KCNQ1. They may be in weak LD in our population and would explain why we failed to detect any KCNQ1 SNP effect on the QTc length. We also hypothesized that allelic variants in the regulatory subunit of the I Ks channel, minK encoded by KCNE1, could influence the channel function, and as a consequence, the length of the QTc interval. We studied two known nonsynonymous polymorphisms, G38S 23, 36 and D85N. 19, 23, 37 Although the G38 allele was shown to be associated with atrial fibrillation, 36 none of the G38S alleles was associated with the QTc length in our French population of healthy subjects. In contrast, the rare N85 allele was four times more frequent in the group with the longest QTc interval than in the group with the shortest QTc. Wei et al 19 described the N85 allele as a risk factor of drug-induced LQT syndrome. In this study, no variation in I Ks current amplitude was observed when N85-minK was coexpressed with wild-type (WT) KvLQT1 in CHO cells, the channels activated more slowly and deactivated to a greater extent after a long diastolic pause, a latent defect that may be unmasked by drug block and render individuals susceptible to acquired LQTS. Recently, the N85 variant was reported in some LQTS patients presenting longer QTc intervals and a higher incidence of cardiac arrhythmia compared to family members carrying only a LQT syndrome mutation. In this study, a marked reduction of I Ks current was observed when the N85-minK variant was coexpressed with the WT KvLQT1 channel in Xenopus oocytes. 38 Whatever the discrepancy about the KvLQT1/N85-minK channel properties expressed in heterologous expression systems, there is evidence that the KCNE1 N85 allele modifies the I Ks channel function leading to a prolongation of the QTc interval length, which means that D85N would be a 'functional' polymorphism. Our association study is in accordance with these studies since 6% (12/198) of healthy subjects with a QTc interval in the upper limit (394 -433 ms) were carriers of the N85 allele compared to 1.5% (3/200) of healthy subjects with shorter QTc interval (o365 ms).
Recent association studies reported the rare allele IVS2-128 A and rs727957 T associated with the prolongation of the QTc length in healthy Caucasian subjects. 23, 35 The former is located in intron 2 and the latter in a haplotype block ending 20 kb upstream of the KCNE1 gene. The functional nature of these SNPs is undetermined but these data indicate that the KCNE1 gene may act as a QTL for the cardiac ventricular repolarization in healthy subjects. Thus, these SNPs represent good candidates to explore the penetrance variability in LQT syndrome patients.
The KCNH2 K897T polymorphism We found that the 2690 C allele, leading to a threonine residue at position 897 of the HERG protein, was more prevalent in the group with the shortest QTc interval. This Our results not only confirmed a hastened cardiac repolarization in both male and female carriers of the 2690 C allele but also suggested that this effect may be dependent on a KCNQ1 polymorphism located in the 3 0 UTR part of the gene (2031 þ 932 A4G). Interestingly, I Kr , underlined by the HERG channels, and I Ks , underlined by KvLQT1/minK channels, were shown to interact both at a functional and a physical level. Indeed, when I Kr is reduced, the Ap is prolonged, causing I Ks activation to increase so as to prevent excessive repolarization delays, 39, 40 and KvLQT1 was found to associate physically with HERG in both CHO cells and native cardiomyocytes, and to increase membrane localization of HERG in CHO cells. 41 The only KCNQ1 allele in interaction with the HERG-T897 allele is located in the 3 0 UTR part of the gene. This KCNQ1 2031 þ 932 A allele, or a yet unidentified polymorphism LD with it, may lead to more stable transcripts, or to a better subcellular targeting as previously shown for other genes. 42 -44 Even if a direct effect on QTc length was not detectable, the KCNQ1 2031 þ 932 A may potentiate the I Kr current displayed by the HERG-T897 channels.
22
SCN5A polymorphisms We studied four SCN5A SNPs which have been previously reported: À92 C4A, 34 1141-3 C4A, 23 1673 A4G (H558R), 15, 33 5457 C4T (D1819D). 33 Almost completely concordant, the 1141-3 A and 1673 G minor alleles were more frequent in the group with the longest QTc interval, whereas the 5457 T minor allele was more frequent in the group with the shortest QTc length. The effects of the 1141-3 C4A (or the 1673 A4G) and the 5457 C4T SNPs were independent, as shown by the haplotype analysis. The association of the 1673 A4G SNP, or H558R, with QT length confirms the result recently published by Aydin et al. 23 This polymorphism is located in the Na þ channel I -II interdomain cytoplasmic linker, and two studies have suggested that it could modulate the effect of arrhythmiacausing SCN5A mutations. 16, 45 However, no difference in Na þ channel activation and inactivation has been observed between the hH1-H558 and the hH1-R558 clones. 16 It is not possible from our results to disentangle the effect of the H558R polymorphism from that of the 1141-3 C4A SNP because of their tight LD. This latter SNP is located in the acceptor splice site in intron 9 and might affect the splicing. The observed effect may also be due to another unknown polymorphism in LD with these two SNPs. The minor allele of the 5457 C4T SNP, located in the last exon of the gene (exon 28) and leading to the synonymous D1819D polymorphism, was associated with the shortest QTc length. Interestingly, Aydin et al 23 described a SNP located in intron 24 of SCN5A (IVS24 þ 116 G4A) with the minor allele associated with a shorter QTc. The functional nature of these variants on the sodium channel activity or expression remains elusive at this point. Indeed, gain of function mutations in SCN5A were associated with a QTc prolongation in LQTS patients, while loss of function mutations did not produce a QTc shortening in Brugada patients.
One potential limitation of our study was that it was restricted to healthy untreated subjects. We excluded patients taking medications susceptible to prolong the QT interval (antiarrhythmics, neuroleptics, antihistaminics, antihypertensive treatments), as well as subjects with cardiovascular diseases or diabetes. For this reason, extrapolation of our results to the general population might be questionable. Replication of the present results in an independent population would greatly strengthen our findings.
The findings of our study are important for a better understanding of the risk of arrhythmias and sudden death in healthy subjects as well as in patients with cardiovascular diseases. Indeed, a prolonged baseline QT interval was shown to predispose patients with coronary artery disease to sudden death 46 or myocardial infarction 47, 48 whereas a short baseline QT interval was associated with reduced mortality in dofetilide-treated patients with moderate to severe heart failure and reduced left ventricular systolic function. 49 Although rare, the SQTS where patients present a drastic decrease of the QTc interval is also linked to life-threatening arrhythmias and sudden death. 12 So KCNH2 2690A4C (K897T) and SCN5A 5457 C4T SNPs would be expected to be protective factors, while KCNE1 253 G4A (D85N), SCN5A 1141-3 C4A and 1673 A4G (H558R) would be risk factors for QT prolongation and onset of arrhythmias in patients with LQT syndrome or with other cardiovascular diseases; the contrary would be expected in patients with a SQTS.
In conclusion, our results suggest that genetic polymorphisms located in the KCNQ1, KCNE1, KCNH2 and SCN5A genes might, independently or in interaction, influence the QTc length in healthy Caucasian subjects. These variants might also modulate the effects of ion channel mutations leading to arrhythmias such as LQT and Brugada syndromes and contribute to the phenotypic variability observed in these disorders.
